Skip to main content
Caplight Logo









Rua Diagnostics

Rua Diagnostics

Private
Westbury, New YorkHealthcare & Life Scienceshttps://www.ruadiagnostics.com/

Last Round

Accelerator

May 27, 2026

Total Funding Raised

$212,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Rua Diagnostics is a diagnostic equipment company that operates a non-invasive diagnostic platform intended for the early detection and monitoring of diseases through breath analysis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Precision Medicine, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

breath diagnosticsnon-invasive diagnosticsAI-powered diagnosticsmicro-gas chromatographyµGCvolatile organic compoundsVOC analysispoint-of-care testingPOCTearly disease detectionbreathalyzer for diseasemedical AIelectronic nosesepsis detectionARDS diagnosticsmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rua Diagnostics Comparables

Compare Rua Diagnostics with similar companies based on industry and business-model similarity.

Rua Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ChromX Health Co., Ltd.
90%
Breathomix
83%
Blu Biotech
83%

Rua Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 27, 2026
AcceleratorApr 2, 2025
DebtOct 1, 2024

Key People

Founding team and executive leadership

Jillian Levovitz

Chief Executive Officer

Executive Team

Rua Diagnostics Investors

Notable investors and investment history

Rua Diagnostics investors
InvestorRounds
I-CREATE AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 58% MoM, reaching 1.5K.

  • May 27, 2026

    $3.65M raised in Seed Round.

Rua Diagnostics Filings

Explore SEC and related filing metadata, where available.

Rua Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Rua Diagnostics's valuation, stock price, and market status.

Is Rua Diagnostics a public or private company?

Rua Diagnostics is a private company.

What is the current stock price of Rua Diagnostics?

Rua Diagnostics is a private company with no public stock price. No recent secondary market data is available.

How much is Rua Diagnostics worth (valuation)?

Valuation information for Rua Diagnostics is not publicly available.

Can I buy Rua Diagnostics stock?

Rua Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Rua Diagnostics's last funding round?

Rua Diagnostics's most recent funding round was Accelerator on May 27, 2026.

Who are the main investors in Rua Diagnostics?

Key investors in Rua Diagnostics include I-CREATE Accelerator.

Will Rua Diagnostics IPO soon?

No public IPO plans have been announced for Rua Diagnostics.

How can I track Rua Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rua Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWestbury, New York
Employee Range4
Year Founded2023
Last FundingMay 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?